1589P Safety of the BNT162b2 mRNA COVID-19 vaccine in oncologic patients undergoing numerous cancer treatment options von Zemel, M., Kian, W., Kestenbaum, E.H., Alguayn, W., Levitas, D., Sharb, A.A., Shalata, W., Rouvinov, K., Nesher, L., Yakobson, A.

Volltext